BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35875003)

  • 1. Causes of Death in Long-Term Nasopharyngeal Carcinoma Survivors.
    Yang SP; Rao MY; Chen QS; Zhou P; Lian CL; Wu SG
    Front Public Health; 2022; 10():912843. PubMed ID: 35875003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
    Pan XX; Liu YJ; Yang W; Chen YF; Tang WB; Li CR
    Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of death in long-term bladder cancer survivors: A population-based study.
    Kong J; Diao X; Diao F; Fan X; Zheng J; Yan D; Huang J; Qin H; Lin T
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e167-e174. PubMed ID: 31111675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A National Study of Survival Trends and Conditional Survival in Nasopharyngeal Carcinoma: Analysis of the National Population-Based Surveillance Epidemiology and End Results Registry.
    Lv JW; Huang XD; Chen YP; Zhou GQ; Tang LL; Mao YP; Li WF; Lin AH; Ma J; Sun Y
    Cancer Res Treat; 2018 Apr; 50(2):324-334. PubMed ID: 28421724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of death in long-term lung cancer survivors: a SEER database analysis.
    Abdel-Rahman O
    Curr Med Res Opin; 2017 Jul; 33(7):1343-1348. PubMed ID: 28426338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of age on survival of locoregional nasopharyngeal carcinoma: An analysis of the Surveillance, Epidemiology, and End Results program database, 2004-2013.
    Huang SJ; Tang YY; Liu HM; Tan GX; Wang X; Zhang H; Yang F; Yang S
    Clin Otolaryngol; 2018 Oct; 43(5):1209-1218. PubMed ID: 29688619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
    Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
    Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Five-Year Survival Rate of Patients with Nasopharyngeal Carcinoma Based on Tumor Response after Receiving Neoadjuvant Chemotherapy, Followed by Chemoradiation, in Indonesia: A Retrospective Study.
    Dwijayanti F; Prabawa A; Besral ; Herawati C
    Oncology; 2020; 98(3):154-160. PubMed ID: 31995803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cause of death during nasopharyngeal carcinoma survivorship: a population-based analysis.
    Zhou J; Jiang Z; Li Y; Shao X; Liao H
    Front Oncol; 2023; 13():1269118. PubMed ID: 37920157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factor analysis in patients with early-stage nasopharyngeal carcinoma in the USA.
    Liu P; Xue XM; Zhang C; Zhou HW; Ding ZW; Jiang YK; Wang L; Shen WD; Yang SM; Wang FY
    Future Oncol; 2023 May; 19(15):1063-1072. PubMed ID: 37283023
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated Risk of Premature Ischemic Stroke in 5-Year Survivors of Nasopharyngeal Carcinoma.
    Chen MC; Kuan FC; Huang SF; Lu CH; Chen PT; Huang CE; Wang TY; Chen CC; Lee KD
    Oncologist; 2019 Sep; 24(9):e891-e897. PubMed ID: 30898891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic Characteristics and Prognosis of Tongue Squamous Cell Carcinoma in Patients with and without a History of Radiation for Nasopharyngeal Carcinoma: A Matched Case-Control Study.
    Zhang P; Zhang L; Liu H; Zhao L; Li Y; Shen JX; Liu Q; Liu MZ; Xi M
    Cancer Res Treat; 2017 Jul; 49(3):695-705. PubMed ID: 27737535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
    Yao JJ; Qi ZY; Liu ZG; Jiang GM; Xu XW; Chen SY; Zhu FT; Zhang WJ; Lawrence WR; Ma J; Zhou GQ; Sun Y
    Radiother Oncol; 2019 Aug; 137():137-144. PubMed ID: 31102988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: Clinical implications for treatment strategies and surveillance.
    Wang J; Huang X; Sun S; Wang K; Qu Y; Chen X; Wu R; Zhang Y; Liu Q; Zhang J; Luo J; Xiao J; Gao L; Xu G; Hu C; Li YX; Yi J
    Cancer Med; 2021 Jun; 10(11):3613-3621. PubMed ID: 33960136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma.
    Liu Y; Liu Q; Wang Z; Chen M; Chen Y; Li X; Huang D; Fan S; Xiong W; Li G; Zhang W
    J Clin Lab Anal; 2020 Aug; 34(8):e23298. PubMed ID: 32697404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.
    Zeng X; Liu G; Pan Y; Li Y
    J Cell Mol Med; 2020 Aug; 24(15):8326-8349. PubMed ID: 32603520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: A large-population retrospective analysis.
    Qu W; Li S; Zhang M; Qiao Q
    Cancer Med; 2020 Sep; 9(17):6147-6158. PubMed ID: 32649056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph Node Status and Outcomes for Nasopharyngeal Carcinoma According to Histological Subtypes: A SEER Population-Based Retrospective Analysis.
    Guo R; Wu H; Wang J; Lian CL; He ZY; Zhang WW; Chen YX; Wu SG
    Adv Ther; 2019 Nov; 36(11):3123-3133. PubMed ID: 31559602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.
    Wang HY; Li YY; Shao Q; Hou JH; Wang F; Cai MB; Zeng YX; Shao JY
    J Transl Med; 2012 Feb; 10():27. PubMed ID: 22321704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.